tiprankstipranks
Trending News
More News >
SuRo Capital (SSSS)
NASDAQ:SSSS

SuRo Capital (SSSS) AI Stock Analysis

Compare
862 Followers

Top Page

SSSS

SuRo Capital

(NASDAQ:SSSS)

Select Model
Select Model
Select Model
Neutral 67 (OpenAI - 5.2)
Rating:67Neutral
Price Target:
$10.00
▲(4.28% Upside)
The score is driven by attractive valuation (low P/E and strong dividend yield) and a constructive earnings narrative around NAV gains and AI-related holdings. Offsetting these positives are weaker quality signals in financial performance—especially negative TTM operating/free cash flow and historically volatile, valuation-driven results—while technicals are neutral-to-slightly supportive.
Positive Factors
AI Investment Strategy
The company's focus on AI investments positions it well for growth in a rapidly expanding sector, potentially leading to significant returns as AI technologies continue to evolve and gain market traction.
Anticipated IPOs
The upcoming IPOs of portfolio companies like CoreWeave signal potential substantial value realization for SuRo Capital, enhancing its investment returns and validating its investment strategy.
Successful Exits
Achieving high returns on exits like Oklo demonstrates SuRo Capital's ability to identify and capitalize on lucrative investment opportunities, supporting its long-term growth and financial health.
Negative Factors
High Debt Levels
The substantial debt levels pose leverage risks, potentially straining cash flow and limiting financial flexibility, which could impact the company's ability to invest in new opportunities or weather economic downturns.
Net Asset Value Decline
The decline in NAV indicates potential challenges in portfolio valuation and performance, which may affect investor confidence and the company's ability to attract new capital.
Volatile Revenue Growth
The volatility in revenue growth suggests instability in earnings, raising concerns about the sustainability of financial performance and the reliability of future cash flows.

SuRo Capital (SSSS) vs. SPDR S&P 500 ETF (SPY)

SuRo Capital Business Overview & Revenue Model

Company DescriptionSuRo Capital Corp. is a business development company. The firm seeks to invest in growing, late stage, venture capital-backed private companies. SuRo Capital Corp. was founded in 2010 and is based in San Francisco, California.
How the Company Makes MoneySuRo Capital makes money primarily through the appreciation and eventual sale of its equity investments in private companies. The company invests in early-to-late-stage venture-backed companies with high growth potential. Revenue is generated when these portfolio companies go public through an IPO, are acquired, or experience significant valuation increases, allowing SuRo Capital to sell its shares at a profit. Additionally, the company may earn income through interest and dividends from debt securities and other investment instruments. Key factors contributing to its earnings include market conditions, the performance of its portfolio companies, and strategic investment decisions.

SuRo Capital Earnings Call Summary

Earnings Call Date:Nov 04, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Mar 17, 2026
Earnings Call Sentiment Positive
The earnings call highlighted strong performance in AI infrastructure investments, particularly with CoreWeave and OpenAI, and strategic moves to enhance shareholder value through dividends and repurchase programs. Despite some market volatility and a $1 million loss from Compliable's dissolution, the overall sentiment is positive, driven by significant gains in AI-related holdings.
Q3-2025 Updates
Positive Updates
AI Infrastructure Investments
SuRo Capital's strategic focus on AI infrastructure has led to significant gains. CoreWeave, OpenAI, and VAST Data are key holdings. CoreWeave now trades at 3x its IPO price, and OpenAI's potential $1 trillion IPO could represent roughly 1/3 of net assets.
Portfolio Valuation Increase
Net asset value increased to $9.23 per share from $8.93, driven by appreciation in key positions and successful monetizations, including $4.7 million in realized gains from CoreWeave.
New Investment in Hyperliquid
SuRo Capital invested $5 million in HL Digital Assets, Inc., which holds a position in HYPE, a digital token of Hyperliquid, one of the fastest-growing decentralized exchanges.
Strong Performance from WHOOP
WHOOP continues to show strong performance with advancements in health technology, contributing significantly to portfolio value.
Dividend Declaration and Share Repurchase
A $0.25 per share cash dividend was declared, with plans for additional dividends. The Board extended the share repurchase program and authorized note repurchases to enhance shareholder value.
Negative Updates
Market Volatility
The company faces intermittent market volatility and geopolitical uncertainty, which could impact future performance.
Dissolution of Compliable
Rebric Inc., doing business as Compliable, approved a plan to dissolve the company, resulting in a $1 million loss for SuRo Capital.
Company Guidance
During the third quarter of 2025, SuRo Capital reported a net asset value (NAV) of $9.23 per share, an increase from $9.18 per share at the end of the second quarter. This growth was driven by significant appreciation in key investments, including CoreWeave, OpenAI, and VAST Data. CoreWeave, one of the fastest-growing infrastructure providers, saw its valuation increase to approximately three times its IPO price, while OpenAI's valuation was marked at a higher $500 billion after recent restructuring and potential IPO discussions valuing it at up to $1 trillion. VAST Data also reportedly increased its valuation more than threefold. SuRo Capital's strategic focus on AI infrastructure and innovation has been validated by these results, which were achieved through early and conviction-driven investments. The company's portfolio, strongly positioned in AI infrastructure, saw gains through disciplined investment processes, resulting in realized gains of $4.7 million from CoreWeave monetizations, alongside a $7.2 million net gain in net proceeds. The board declared a $0.25 per share cash dividend, reflecting confidence in the portfolio's strength and liquidity, with plans for further dividends based on anticipated near-term monetizations.

SuRo Capital Financial Statement Overview

Summary
Income statement shows a strong swing back to profitability in TTM, but results are highly volatile and revenue is small and declining. Balance sheet leverage appears manageable, yet book value/returns are valuation-sensitive. Cash flow is the key weakness with materially negative TTM operating cash flow and free cash flow, increasing reliance on investment realizations and market conditions.
Income Statement
64
Positive
TTM (Trailing-Twelve-Months) results show a sharp swing back to strong profitability (very high operating and net margins) versus a loss in 2024, indicating earnings power can rebound quickly. However, revenue is small and declining (TTM down ~15% after a slight decline in 2024), and the multi-year record is highly volatile with large profit years followed by large loss years—typical of investment/valuation-driven earnings and a key stability risk.
Balance Sheet
72
Positive
Leverage looks manageable with debt-to-equity around ~0.32 in TTM (Trailing-Twelve-Months) and equity representing a meaningful capital base, supporting balance-sheet flexibility. That said, equity and assets have moved materially over time, and returns on equity have swung from strongly positive (TTM ~36%) to negative (2024), highlighting valuation sensitivity and potential variability in book value.
Cash Flow
38
Negative
Cash generation is the main weak spot: TTM (Trailing-Twelve-Months) operating cash flow and free cash flow are both meaningfully negative (about -$21M) and free cash flow fell sharply versus the prior period. While the company has posted positive cash flow in some years, the history is inconsistent with several periods of sizable outflows, making liquidity and funding needs more dependent on market conditions and portfolio realizations.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.35M4.67M6.60M3.46M1.47M1.82M
Gross Profit80.97M-24.34M20.25M-118.86M157.78M89.43M
EBITDA68.98M-38.12M5.07M-132.18M147.07M75.34M
Net Income68.98M-38.12M5.07M-132.18M147.07M75.34M
Balance Sheet
Total Assets308.30M231.60M277.60M284.41M462.32M478.88M
Cash, Cash Equivalents and Short-Term Investments54.59M20.04M28.18M40.12M198.44M45.79M
Total Debt73.48M73.25M73.75M73.39M73.03M37.40M
Total Liabilities76.51M74.03M74.24M74.39M97.47M177.29M
Stockholders Equity231.79M157.57M203.36M210.02M364.85M301.58M
Cash Flow
Free Cash Flow-20.86M2.37M-10.35M-11.84M-142.06M76.56M
Operating Cash Flow-20.86M2.37M-10.35M-11.84M-142.06M76.56M
Investing Cash Flow38.33M0.0012.73M-98.72M325.71M-100.19M
Financing Cash Flow4.38M-10.51M-14.32M-47.76M-31.01M24.56M

SuRo Capital Technical Analysis

Technical Analysis Sentiment
Positive
Last Price9.59
Price Trends
50DMA
9.39
Positive
100DMA
9.23
Positive
200DMA
8.09
Positive
Market Momentum
MACD
0.04
Negative
RSI
52.77
Neutral
STOCH
65.88
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SSSS, the sentiment is Positive. The current price of 9.59 is above the 20-day moving average (MA) of 9.54, above the 50-day MA of 9.39, and above the 200-day MA of 8.09, indicating a bullish trend. The MACD of 0.04 indicates Negative momentum. The RSI at 52.77 is Neutral, neither overbought nor oversold. The STOCH value of 65.88 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SSSS.

SuRo Capital Risk Analysis

SuRo Capital disclosed 72 risk factors in its most recent earnings report. SuRo Capital reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

SuRo Capital Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
69
Neutral
$250.48M7.369.43%17.28%206.13%298.86%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
67
Neutral
$239.89M3.9335.45%5.39%
64
Neutral
$244.41M7.4017.13%13.03%315.14%116.85%
61
Neutral
$158.52M16.083.51%21.24%-55.82%-4.97%
55
Neutral
$142.78M-33.35-2.25%14.03%-34.92%-132.22%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SSSS
SuRo Capital
9.34
4.40
89.03%
WHF
WhiteHorse
6.71
-2.23
-24.94%
TPVG
TriplePoint Venture Growth
5.96
-0.77
-11.44%
MRCC
Monroe Capital
6.42
-1.11
-14.74%
NXDT
NexPoint Diversified Real Estate Trust
4.79
0.16
3.46%
LIEN
Chicago Atlantic BDC
10.49
-0.21
-1.96%

SuRo Capital Corporate Events

Business Operations and StrategyDividendsFinancial DisclosuresPrivate Placements and Financing
SuRo Capital Expands AI Infrastructure Investment With TensorWave
Positive
Jan 12, 2026

In 2025, SuRo Capital reported that its portfolio comprised 35 companies, heavily weighted toward privately held, high‑growth businesses, with performance driven by growing recognition of the value of its investments in artificial intelligence and AI infrastructure. During the fourth quarter of 2025, the firm realized liquidity from several positions—including proceeds from CW Opportunity 2 LP and a full exit from Forge Global—supporting total cash dividends of $0.50 per share paid on July 31 and December 5, 2025, while simultaneously committing up to $20 million to a Magnetar-managed vehicle invested in TensorWave to deepen its exposure to next‑generation AI infrastructure; as of January 12, 2026, $5 million of that commitment had been funded, and SuRo signaled it will release full fourth-quarter and full-year 2025 results in the week of March 9, 2026, underscoring a strategy of disciplined realizations and reinvestment in AI-focused assets for shareholders’ long-term benefit.

The most recent analyst rating on (SSSS) stock is a Buy with a $12.00 price target. To see the full list of analyst forecasts on SuRo Capital stock, see the SSSS Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jan 13, 2026